There has been considerable interest in the role that cytochrome P450\'s unusual thiolate ligand plays in catalysis.^[@R1]^ Only thiolate ligated heme proteins are known to activate C-H bonds, suggesting a critical role for the ligand in this process. Strong electron donation from the axial thiolate has been proposed to facilitate both oxygen and C-H bond activation.^[@R2]-[@R6]^

The principal intermediate in P450 catalysis is a high-valent ferryl radical species called compound I (P450-I). Until recently, the reactive nature of this intermediate precluded its electronic and structural characterizations.^[@R5],[@R7]-[@R9]^ As a result, researchers often turned to model systems for insight into P450 chemistry. Important in this regard have been studies with synthetic metal-oxo porphyrins.^[@R10]-[@R16]^

Investigations with these systems have shown that reactivity with respect to oxygen transfer increases with electron donation from the axial ligand.^[@R10]-[@R14]^ These studies have typically involved synthetic iron porphyrins coordinated by a series of hard ligands (e.g. F^−^, Cl^−^, AcO^−^, CF~3~SO~3~^−^). Synthetic systems with thiolate ligation are rare, but Nagano and Higuchi reported an iron porphyrin (the "Swan-Resting", S.R.) complex, which can be prepared with either thiolate or imidazole axial ligation.^[@R15],[@R16]^ In competitive oxidations of cyclooctane and cyclooctene, the thiolate ligated S.R. complex was found to be an order of magnitude more likely to perform C-H bond activation than the imidazole ligated system, supporting a unique role for P450\'s axial thiolate ligand.^[@R16]^

The thiolate ligated heme enzyme chloroperoxidase (CPO) has proven to be another important model system for the study of P450 chemistry.^[@R2]^ CPO\'s main function is thought to lie in the incorporation of chloride into the antibiotic caldariomycin, but the enzyme is also known to hydroxylate a range of *activated* hydrocarbons (BDFE ≤ 91 kcal/mol).^[@R17]^ Chloroperoxidase compound I (CPO-I) is relatively stable (compared to P450-I) permitting early spectroscopic characterizations of CPO-I that have provided valuable insight into the electronic and geometric structures of a thiolate ligated compound I.^[@R18],[@R19]^

There is an important difference, however, between CPO and P450: CPO does not oxidize unactivated hydrocarbons, such as cyclohexane (BDFE \~ 101 kcal/mol).^[@R17]^ It is possible that this difference in reactivity may be linked, at least in part, to substrate access. P450s have large flexible substrate binding pockets, providing ready access to targeted C-H bonds, while entry to the CPO-I active site appears to be more limited.^[@R20],[@R21]^ Evidence suggests, however, that more than substrate access is at play.^[@R22],[@R23]^ CPO-I epoxidizes terminally unsaturated fatty acids, indicating that the molecules' aliphatic termini can reach the ferryl moiety. Yet, as we will show, the reaction with fully saturated fatty acids is not observed.

The disparity in C-H bond hydroxylation competence suggests an inherent difference in the reactivity of compound I in P450 and CPO. This raises an interesting question: Is P450\'s greater propensity for C-H bond activation consistent with the insights gained from synthetic model compounds? Is the thiolate ligand more donating in P450? P450 and CPO have distinct protein folds with different hydrogen-bonding patterns to the thiolate.^[@R20]^ The ability of these non-covalent interactions to tune the electronic properties of the axial ligand has been a topic of interest and debate.^[@R24]-[@R33]^

X-ray crystallography has revealed that, in both systems, the proximal thiolate sits in what has been termed the "cys-pocket". The residues directly following the cysteine coil around the thiolate, presenting amide N-H\'s for hydrogen bonding to the thiolate ligand. The cys-pocket of CPO and P450 are shown in [Figure 1](#F1){ref-type="fig"}.^[@R20],[@R21],[@R34],[@R35]^ Comparison reveals that CPO has one less amide N-H available for hydrogen bonding to the thiolate. As result, it has been thought that H-bonding to the axial thiolate is stronger in P450 than in CPO.^[@R28]^ However, magnetic circular dichroism (MCD) experiments suggest that at least two of P450\'s putative hydrogen bonds may have little effect on the electronic structure.^[@R32],[@R33]^

Recently, we reported that compound I could be prepared in three different P450s, in CYP119A1 and CYP119A2 from the thermophillic organisms *Sulfolobus acidocaldarius* and *Sulfolobus tokodaii*, and a Y352F CYP158A2 variant (CYP158A2\*) from *Streptomyces coelicolor*, in which tyrosine 352 was replaced with a phenylalanine.^[@R5]-[@R7]^ This has opened the door for detailed spectroscopic characterizations of P450-I, facilitating crucial comparisons with CPO-I. Spectroscopic measurements indicate that \|J/D\|, the ratio of the exchange coupling to the zero-field splitting, is \~30% larger in P450-I than CPO-I (1.3 vs. 1.0).^[@R5]^ This increase in \|J/D\| suggests a significant difference in the electronic and/or geometric structures of these intermediates. In an effort to provide insight, we have performed variable temperature Mössbauer and Fe K-edge X-ray absorption measurements on CPO-I and P450-I. These measurements suggest weaker hydrogen bonding to and greater electron donation from the thiolate in P450.

Results {#S1}
=======

Stopped-Flow Kinetics Measurements {#S2}
----------------------------------

Direct comparisons of rates of substrate oxidation by P450-I and CPO-I have not been made. Here we compare the reactivity of CPO-I and CYP119A1-I with hexanoic and 5-hexenoic acid. Stopped-flow measurements indicate that CPO-I readily reacts with 5-hexenoic acid with a rate constant of 7 × 10^3^ M^−1^s^−1^ at 4°C.^[@R36]^ However, no reaction is observed with hexanoic acid. In contrast, CYP119A1-I oxidizes both hexanoic acid and 5-hexenoic acid at rates of 4 × 10^4^ and 3 × 10^5^ M^−1^s^−1^ at 4°C, respectively ([Figure 2](#F2){ref-type="fig"}).

Variable Temperature Mössbauer (VTM) Measurements {#S3}
-------------------------------------------------

Compound I is best described as having an *S*=1 iron(IV)oxo unit exchange coupled to an S=1/2 ligand-based radical.^[@R5]^ The location of this radical in P450s (on the thiolate, the porphyrin, or some mixture of both) is an important and unresolved question in the field, with implications for reactivity and the reliability of quantum chemical calculations. The exchange coupling (*J*) between the iron(IV)oxo unit and the ligand-based radical produces doublet and quartet states, which are mixed by the zero-field splitting (*D*) of the ferryl moiety, resulting in three Kramers doublets.^[@R5],[@R18]^

Thiolate ligation is known to affect the exchange coupling of compound I. EPR measurements on CPO-I have revealed strong antiferromagnetic coupling between the *S*=1 ferryl moiety and the *S*=1/2 radical (\|*J*\| = 35 cm^−1^ for CPO-I).^[@R18]^ Synthetic model complexes have strong ferromagnetic interactions with \|*J*\| values ranging between 25 and 60 cm^−1^, while the coupling in histidine ligated peroxidases is weakly ferromagnetic, \|*J*\| = 0-10 cm^−1^.^[@R37]-[@R39]^ It has been suggested that antiferromagnetic coupling in the thiolate ligated systems can be understood in terms of delocalization of the porphyrin radical onto the axial ligand.^[@R39],[@R40]^

EPR measurements have shown that \|J/D\| is \~30% larger in P450-I than in CPO-I. A larger value of \|*J*\| could be the hallmark of increased sulfur spin density and/or a shortened Fe-S bond, both of which would suggest increased electron donation from the axial thiolate ligand. The magnitudes of J and D cannot be determined directly from CW EPR experiments, but they can be obtained from relaxation studies. Between 10 and 60 K, electronic relaxation in compound I proceeds predominantly through an Orbach mechanism.^[@R18]^ T~1~ (the electronic relaxation time) is determined by Δ, the energy splitting between the middle and ground Kramers doublets ([Eq. 1](#FD1){ref-type="disp-formula"}). Because Δ is solely a function of *J* and *D* ([Eq. 2](#FD2){ref-type="disp-formula"}), and the value of *J/D* is known from EPR, T~1~ measurements can uniquely determine *J* and *D*. $$\left. W\left( T \right) = 1\slash T_{1}\left( T \right) = A\Delta^{3}\frac{1}{\exp\left( \Delta\slash T \right) - 1} \right.$$ where A is a system-dependent constant (mm s^−1^ K^−3^), T is the temperature (K), and Δ is given by, $$\Delta = \frac{1}{2} \ast \sqrt{9J^{2} - 4DJ + 4D^{2}}$$ This result, which assumes axial symmetry (*E/D* = 0), was obtained from the following spin Hamiltonian: $${\hat{\mathcal{H}}}_{S} = D\left( {\hat{\mathbf{S}}}_{\mathbf{1}\mathbf{z}}^{\mathbf{2}} - 2\slash 3 \right) + J{\hat{\mathbf{S}}}_{1}\bullet{\hat{\mathbf{S}}}_{2}$$ where **Ŝ~1~** and **Ŝ~2~** are the spin operators for the ferryl moiety and ligand-based radical, respectively. *J* \> 0 indicates antiferromagnetic coupling.

Typically, measurements of the electronic spin relaxation rates are performed using EPR methods. However, in the current case, we have found ^57^Fe Mössbauer spectroscopy to be more suitable, as it gives a wider accessible temperature range and thus improved quality of data analysis. [Figure 3](#F3){ref-type="fig"} shows that the Möossbauer spectrum of compound I collapses to a quadrupole doublet as the temperature increases above 4.2 K. This collapse is due to the "averaging-out" of the magnetic interactions between the electronic spin and the ^57^Fe nucleus as the electronic relaxation rate (1/T~1~) approaches and exceeds the intrinsic width of the Mössbauer transition (\~ 10^7^ s^−1^).^[@R41]^ It is clear from the spectra shown in [Fig. 3](#F3){ref-type="fig"} that CYP119A1-I relaxes more slowly than CPO-I.

Mössbauer spectra are typically fit in the slow (not averaged-out) or fast (completely averaged-out) relaxation regimes. However, it has been shown that intermediate relaxing spectra can be analyzed to obtain electronic relaxation rates.^[@R41],[@R42]^ To extract the relaxation rates from the Mössbauer spectra, fits of the 4.2 K data were first performed to obtain Mössbauer parameters in the slow relaxation limit. For fits of intermediate relaxing data ([Fig. 3](#F3){ref-type="fig"} and [Supplementary Tables S1 and S2](#SD1){ref-type="supplementary-material"}), the Mössbauer parameters were constrained to the values obtained at 4.2 K: Only the electronic relaxation rate (W=1/T~1~) was allowed to vary. As can be seen from [Fig. 3C](#F3){ref-type="fig"}, for most of the temperature range, the data show a logarithmic dependence on the inverse temperature (1/T), which is well modeled by an Orbach process. Best fits to [Eq. 2](#FD2){ref-type="disp-formula"} provide the following Δ values: $$\begin{aligned}
 & {\Delta_{{CYP}_{119}A_{1} - I} = 110 \pm 5\; K} \\
 & {\Delta_{{CPO} - I} = 84 \pm 3\; K.} \\
\end{aligned}$$ Inserting Δ and the ratio \|J/D\| into [Eq. 2](#FD2){ref-type="disp-formula"} yields the following values for J and D: $$\begin{aligned}
 & {D_{{CYP}_{119}A_{1} - I} = 40\;{cm}^{- 1}\;\left( 58\; K \right),\quad J_{{CYP}_{119}A_{1} - I} = 52\;{cm}^{- 1}\;\left( 76\; K \right);} \\
 & {D_{{CPO} - I} = 39\;{cm}^{- 1}\;\left( 56\; K \right),\quad J_{{CPO} - I} = 40\;{cm}^{- 1}\;\left( 57\; K \right);} \\
\end{aligned}$$ The values obtained for CPO-I are in reasonable agreement with those reported previously (D = 52 K, J = 53 K).^[@R18]^ Our measurements indicate that the zero-field splitting is similar in CPO-I and P450-I. The variation in \|J/D\| results almost exclusively from a difference in the exchange coupling. The larger J in P450-I suggests greater spin density on the axial thiolate and/or a shorter Fe-S bond relative to CPO-I.

X-ray Absorption Measurements {#S4}
-----------------------------

### Fe K-edge XANES {#S5}

XANES data of CPO-I and ferric CPO look similar to those of CYP119A1-I and ferric CYP119A1, respectively ([Supplementary Figure S1](#SD1){ref-type="supplementary-material"}). The CYP119A1 ferric edge lies \~1.8 eV lower in energy than that of CYP119A1-I, while in CPO this difference was slightly smaller, \~1.6 eV. In both systems, the pre-edge feature resulting from the compound I species is larger and at higher energy than that of the ferric species. The pre-edge feature of CPO-I is noticeably larger than that of the P450-I sample ([Supplementary Figure S1](#SD1){ref-type="supplementary-material"}). This is due in large part to the presence of \~30% ferric enzyme in the P450-I sample. Fits of the pre-edge features indicate that the pre-edge intensity of CPO-I is 14 ± 8% larger than that of CYP119A1-I ([Supplementary Figure S2](#SD1){ref-type="supplementary-material"}).^[@R43],[@R44]^

Given the magnitude of the uncertainty in the relative intensity, we calculated pre-edge spectra (See Methods section) to determine if the observed metal-ligand bond lengths (discussed below) are consistent with the observed variation in pre-edge intensity. Using methods outlined by DeBeer and Neese,^[@R43]^ we find that the pre-edge feature in CPO-I is predicted to be \~17% larger than in CYP119A1-I (27 units compared to 23 units, respectively).

### Fe K-edge EXAFS {#S6}

Extended X-ray Absorption Fine Structure (EXAFS) measurements have been performed for both CYP119A1-I and CPO-I to resolve and compare Fe-S and Fe-O bond distances in each species. Multiple measurements were performed (three for CYP119A1-I and four for CPO-I) on independently prepared samples, during different experimental runs.

[Figure 4](#F4){ref-type="fig"} shows the EXAFS and Fourier transforms for CYP119A1-I and CPO-I. Our analysis of the EXAFS data reveals that the Fe-S bond distance in CYP119A1-I is \~0.10 Å shorter than the Fe-S bond distance in CPO-I (2.388 Å compared to 2.481 Å). In addition, the Fe-O distance in CYP119A1-I is longer (1.670 Å) than in CPO (1.661 Å). Best-fit parameters and 90% confidence intervals for the metal-ligand distances can be found in [Table 1](#T1){ref-type="table"}.

EXAFS experiments were also performed on compound I intermediates prepared in CYP119A2 and CYP158A2\* ([Table 1](#T1){ref-type="table"}). Averaging all five P450-I measurements yields an Fe-S distance of 2.391 Å and an Fe-O distance of 1.670, essentially identical to the results obtained for CYP119A1. EXAFS measurements of the ferric enzymes produced Fe-S distances of 2.21 Å for P450 and 2.24 Å for CPO^3^ ([Supplementary Table S3 and Supplementary Figure S3](#SD1){ref-type="supplementary-material"}).

Discussion {#S7}
==========

Experiments with synthetic metal-oxo complexes have shown that donating axial ligands enhance reactivity with respect to oxygen transfer and C-H bond activation.^[@R10]-[@R16]^ Density functional calculations have linked this increased reactivity to a strengthening of the O-H bond formed during C-H bond cleavage.^[@R13],[@R14]^ In P450, an increase in the O-H bond strength, D(FeO-H), can be understood in terms of a relative stabilization of the metal-hydroxide (or compound II) species with respect to compound I. This increases the driving force, lowering the activation barrier for H-atom abstraction.

Calculations have shown that D(Fe=O) of compound I and D(FeO-H) of compound II are inversely correlated, with the driving force for H-atom abstraction increasing as the Fe=O bond weakens.^[@R13]^ The shorter Fe-S bond in P450-I allows for greater electron donation into the ferryl π\* orbitals, weakening the Fe=O bond. As a result, the Fe=O bond is longer in P450-I than in CPO-I. Although the difference in Fe=O bond lengths is small, \~0.01 Å on average, it is significant for such a short bond. Importantly, our measurements of the Fe=O bond have a standard deviation of \~0.005 Å.

Recently, we reported a similar bonding pattern in compound II. The Fe-S bond is 0.12 Å shorter in P450-II than in CPO-II, while the Fe-OH bond is 0.02 Å longer.^[@R3],[@R6]^ The compound II bond distances also appear to be consistent with the known reactivities of these systems. Calculations on ferryl porphyrins have indicated that the activation barrier for H-atom abstraction is inversely correlated to the Fe-O bond length in the transition state, which itself is related to the Fe-OH bond length in compound II.^[@R12]^ Systems with the most donating ligands were predicted to have the longest Fe-OH bonds and be the most reactive with respect to C-H bond activation.^[@R12]^

Given that the local coordination environments in CPO and P450 are identical, why is the Fe-S bond \~0.1 Å shorter in P450? This difference in metal-ligand bonding likely derives from variations in non-covalent interactions in the secondary coordination sphere. It has been thought that H-bonding to the axial thiolate is stronger in P450 than in CPO.^[@R28]^ However, examination of the crystal structures of the ferric enzymes suggests that this is not the case ([Figure 1](#F1){ref-type="fig"}).^[@R34],[@R35]^

Only one of the putative H-bonding interactions in the CYP119A1 structure has an S\-\--H distance (2.55 Å) less than the sum of the respective Van der Waals radii (r~S~^VDW^ + r~H~^VDW^ = 1.8 Å + 1.2 Å = 3.0 Å), and this H-bonding interaction has an N-H\-\--S angle of \~130°, which is far from the optimal angle of 180°. The two additional S\-\--H interactions in P450 (2 and 4 in [Figure 1](#F1){ref-type="fig"}) have poor angles combined with S\-\--H distances over 3.0 Å, which suggests that their effect on the electronic properties of the thiolate is minimal. This is consistent with the results of magnetic circular dichroism (MCD) experiments on CYP101 variants, in which interactions 2 and 4 were individually removed through proline substitution.^[@R32]^ In contrast to P450, the ferric CPO structure shows a strong H-bonding interaction with an S\-\--H distance of 2.33 Å and an N-H\-\--S angle of 172°. Notably, the weakest H-bonding interaction in CPO is comparable to the best interaction in P450.

Importantly, the hydrogen-bonding observed in the CYP119A1 structure is typical of P450s ([Figure 1](#F1){ref-type="fig"} caption). P450s have a unique protein fold with a conserved orientation of the proximal helix that forms the cys-pocket. The different hydrogen-bonding patterns observed in CPO and P450 are dictated by the orientation of this helix. In P450s, the proximal helix runs parallel to the heme plane, while in CPO the helix is almost perpendicular to the porphyrin ([Figure 1](#F1){ref-type="fig"}).^[@R20]^ In the latter orientation, the axial thiolate caps the alpha helix, allowing for greater interaction with the amide protons as well as inductive effects, which could further strengthen the non-covalent interactions. While one does not expect H-bonding metrics in other (i.e. non-ferric) forms of these enzymes to be identical to those reported in [Figure 1](#F1){ref-type="fig"}, one does expect variations in hydrogen-bonding due to the orientation of the proximal helix to persist. Indeed, this is consistent with resonance Raman experiments on the ferrous-CO adducts of CPO and P450 as well as EPR measurements on the ferric enzymes, both of which suggest greater hydrogen bonding in CPO.^[@R45]-[@R47]^

The Fe-S bond length of thiolate ligated iron porphyrins is known to increase with increasing H-bonding.^[@R25],[@R48]^ This is consistent with our EXAFS measurements. The weaker H-bonding in P450 (allowing for greater electron donation from the axial thiolate) may in part explain the enzyme\'s greater propensity for C-H bond activation. Recall that \|*J*\| is 30% larger in P450-I than in CPO-I. Our data suggest that \|*J*\| is correlated with the Fe-S distance, and, as such, may be used to gauge electron donation from the axial ligand. An increase in \|*J*\| is consistent with a shorter Fe-S distance and/or increased axial ligand spin density. Efforts to quantify the latter are underway.

Methods {#S8}
=======

Materials {#S9}
---------

*meta*-chloroperbenzoic acid (*m*-CPBA, \<77%, Aldrich) was purified to 99% following established techniques.^[@R6]^ Peracetic acid was obtained from Sigma Aldrich and acetonitrile from EMD. All buffers were prepared by standard techniques and the pH was measured at 4°C. Given that our EXAFS and Mössbauer experiments were performed at low temperature a quick comment about the temperature dependence of buffer pH is warranted. It is known that buffer pH can vary significantly with temperature. The pH of 100 mM Tris buffer, for example, changes by +2.3 units on going from 293 K to 77 K, while the pH of 100 mM phosphate buffer changes by approximately two units in the opposite direction.^[@R49]^ It is less well known, however, that concentrated (\~ mM) protein solutions can 'buffer the buffer' against these temperature -dependent changes. Addition of 600 μM bovine serum albumin to the same Tris and phosphate buffers effectively abolishes the temperature dependence of the pH: the pH changes by +0.1 units over the same temperature range.^[@R49]^ Our recent measurements of the P450-II pK~a~ are in agreement with this result.^[@R6]^ Using Mössbauer (4.2 K) and stopped-flow UV/Visible absorption (277 K) spectroscopies, we obtained the same pK~a~ (±0.1 units) at these vastly different temperatures, indicating that the pH of our samples was not significantly changed upon freezing.

Purification of CYP119A1 and CYP119A2 {#S10}
-------------------------------------

CYP119A1 and CYP119A2 were overexpressed in BL21-CodonPlus-RIL cells. Protein was purified as reported previously.^[@R5]^ A Source 30Q column was substituted for the PBE94 chromatofocusing column employed by Ortiz de Montellano and coworkers. Only protein fractions with a purity ratio R~Z~ (Abs~416nm~/Abs~280nm~) of ≥ 1.65 were collected, pooled, and used for experiments.^[@R5]^

CYP119A1-I and CYP119A2-I Preparation {#S11}
-------------------------------------

Both CYP119A1-I and CYP119A2-I samples were prepared as previously described with slight modifications by reacting \~6 mM ferric protein in 100 mM potassium phosphate buffer at pH 7 with \~24 mM *m*-CPBA in 30% acetonitrile in water, in a 2:1 mixture.^[@R5]^ The aqueous reaction mixture was sprayed into liquid ethane (90 K) \~2 ms after mixing. Liquid ethane was subsequently removed under vacuum in an isopentane bath (\~128 K), after which samples were packed into Mössbauer or EXAFS cups under liquid nitrogen. Both CYP119A1-I and CYP119A2-I samples contained \~30% ferric enzyme.

Growth, Purification, and Preparation of Y352F CYP158A2 (CYP158A2\*) Compound I {#S12}
-------------------------------------------------------------------------------

CYP158A2\* was obtained as reported previously.^[@R6]^ CYP158A2\*-I samples were prepared by reacting ferric protein (6 mM, Rz ≥ 2.00, in 100 mM tris-HCl buffer, pH 7.0) with a solution of *m*-CPBA (24 mM, 30% acetonitrile) in a 2:1 mixture (v/v). Reactants were mixed and quenched into liquid ethane \~ 2 ms after mixing. Samples were packed into Mössbauer and EXAFS sample cups for spectroscopic analysis at a final protein concentration of 4 mM. The final concentrations of *m*-CPBA and acetonitrile were 8 mM and 10% (v/v), respectively.

Purification of Chloroperoxidase {#S13}
--------------------------------

Chloroperoxidase was obtained from the filamentous fungus *Caldariomyces fumago* (ATCC 16373) and purified according to established protocols.^[@R19]^ Protein fractions with an R~z~ (Abs~400nm~/Abs~280nm~) value of ≥ 1.45 were used for experiments.

CPO-I Preparation {#S14}
-----------------

CPO-I samples for VTM and XAS measurements were prepared as previously described^[@R19]^ with slight modifications by reacting \~7 mM ferric CPO with \~150 mM peracetic acid, both in 100 mM potassium phosphate (Kphos) buffer pH 6.5, in a 2:1 mixture. The pH of the peracetic acid solution was adjusted back to pH 6.5 after the addition of peracetic acid. The aqueous reaction mixture was sprayed into liquid ethane (90 K) \~2 ms after mixing. Liquid ethane was removed under vacuum in an isopentane bath (\~128 K), after which samples were packed into Mössbauer or EXAFS cups under liquid nitrogen.

Stopped-Flow Kinetics Measurements {#S15}
----------------------------------

Kinetic experiments with CYP119A1, experimental setup, and data analyses were similar to those described previously.^[@R5]^ In a typical kinetic experiment involving CPO, an aqueous solution containing 100 mM Kphos (pH 4.0) and 20 μM CPO was mixed with an aqueous solution of 20 μM peracetic acid and aged until exponential decay of compound I was apparent (2 seconds). The resulting solution, typically consisting of \~60% CPO-I, was then mixed with a buffered (pH 4.0) aqueous solution of 5-hexenoic acid or hexanoic acid (0-24 mM). The decay of CPO-I was monitored at 690 nm.

Mössbauer Data Collection and Analysis {#S16}
--------------------------------------

Mössbauer spectra were recorded on a spectrometer from SEE CO (formerly WEB research) operating in constant acceleration mode in transmission geometry. The sample was kept inside an SVT-400 dewar from Janis with a magnetic field of 54 mT applied parallel to the γ-beam. Spectra were recorded at the indicated temperatures. The quoted isomer shifts are relative to the centroid of the spectrum of a metallic foil of α-Fe at room temperature. Temperature studies for each sample (CPO-I, CYP119A1-I, and ferric CYP119A1) were performed in duplicate. Data analysis was performed using the program WMOSS from WEB research. Analysis of variable temperature data was performed with a modified version of the FORTRAN program CPLRXF by C. Schulz, using methodology described by Schulz et al.^[@R42]^ No assumptions about the nature of the relaxation process were made. Instead, the relaxation rate (W) was provided externally and then used directly to construct the relaxation matrix. CPLRXF was interfaced and fitting was performed through the MATLAB programming environment.

XAS Sample Preparation {#S17}
----------------------

All XAS samples were prepared in modified Mössbauer cups. The bottom of each cup was removed, and the opening was covered with Kapton tape. Freeze-quenched protein was packed into the modified cups under liquid nitrogen. Samples were stored in liquid nitrogen until XAS measurements were performed.

XAS Data Collection and Analysis {#S18}
--------------------------------

X-ray absorption measurements were performed at the Stanford Synchrotron Radiation Laboratory (SSRL) on beam line 7-3 at \~ 10 K as previously described with slight modifications.^[@R6]^ The data were collected by using a Si(220) φ = 0° double-crystal monochromator with a 9.0 keV cutoff for harmonic rejection. Data sets were collected in fluorescence mode with a 30-element Ge detector.

To avoid photoreduction during XAS measurements, the sample position in the beam was adjusted after each scan so that a previously unexposed portion of the sample was examined. Each EXAFS data set consisted of \~20 first scans. All CYP119A1-I and CYP119A2-I samples contained \~70% compound I as judged by Mössbauer spectroscopy (the remainder was ferric enzyme). CYP158A2\*-I contained \~85% compound I, while CPO-I samples contained ≥95% compound I.

Raw XAS data were fit over the region k=3--15. Fits, performed as previously described with some modifications,^[@R3],[@R19]^ included first and second shell atoms and one multiple-scattering component. In all cases, the second shell was comprised of α- and meso- carbons and the Fe--C~α~--N--Fe multiple-scattering paths (N = 8, 4, and 16, respectively). The scale factor, S~0~, was set to 0.9. Fits of the CYP119A1-I and CYP119A2-I data accounted for a \~30% ferric component by including a Fe-S scattering path fixed at the Fe-S distance obtained from experiments on ferric P450. The ability to resolve two similar (i.e. both Fe-S) but different scattering paths in EXAFS experiments is determined by the resolution of the experiment. The resolution in EXAFS is given by the formula Δr ≥ π/(2\*Δk), where Δr is the difference in the two path lengths and Δk is k-range over which data is fit. Our EXAFS data were fit from k=3-15 Å^−1^, giving a resolution of 0.13 Å. This means the two scattering paths must differ by ≥ 0.13 Å for us to be able to resolve and identify their individual contributions. The difference between the Fe-S distances found in ferric enzyme and compound I is 0.18 Å, (0.05 Å longer than required). Thus, the ferric component of the sample does not affect our measurement of the compound I Fe-S distance. The two scattering contributions can be readily resolved. The results obtained from fitting each independent sample were averaged to obtain final metal-ligand distances and standard deviations. Energies were calibrated using an iron foil (7111.2 eV) and edge positions were obtained from the first derivative of the data using EXAFSPAK (1.0 eV smoothing, third-order polynomial).

Pre-edge data was fit using the EDG_FIT portion of EXAFSPAK.^[@R50]^ Pre-edge peaks were modeled with pseudo-Voigt shaped lines set to a 50:50 (Lorentzian: Gaussian) ratio. Fits of multiple energy ranges were averaged to obtain pre-edge areas. In addition, some of the fits included a post edge or background curve that was allowed to vary.^[@R43]^ Areas of the fits were determined using the method of Westre *et al.*^[@R41]^ Fits of the P450-I data contained a ferric component with parameters constrained to the values obtained from fits of the ferric data. Pre-edge calculations were performed using methods outlined by DeBeer and Neese with minor modifications (SI).^[@R43]^
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![P450 displays weaker/poorer H-bonding interactions compared to CPO. H-bonding metrics and Fe-S distances from the crystal structures of (a) ferric CPO (2J19) and (b) ferric CYP119A1 (1IO7) are shown. The H-bonding metrics for CYP119A1 are typical of P450s. Average distances (angles) for the four P450s discussed in this paper \[CYP119A1, CYP119A2 (3B4X), CYP158A2 (1SE6), and CYP101 (1PHC)\] are: ① 2.59±0.12Å (124±3°); ② 3.59±0.08Å (76±4°); ③ 2.41±0.25Å (161±6°); ④ 3.09±0.18Å (99±3°). Protein Data Bank accession codes for each structure are given in parentheses.](nihms-702170-f0001){#F1}

![Rates of substrate oxidation by CPO-I and CYP119A1-I. Both CPO-I and P450-I readily epoxidize 5-hexenoic acid, indicating that the aliphatic termini of fatty acids can reach the ferryl moiety. Yet, only P450-I reacts with hexanoic acid, hydroxylating it at the ω-1 position. This disparity in C-H bond hydroxylating competence suggests an inherent difference in the reactivity of compound I in P450 and CPO. Experimental details are given in Methods.](nihms-702170-f0002){#F2}

![Variable temperature Mössbauer data for (a) CYP119A1-I and (b) CPO-I. With increasing temperature, the Mössbauer spectrum of CPO-I collapses towards a quadrupole doublet more quickly than that of P450-I, indicating that P450-I has a slower electronic relaxation rate than CPO-I. Fits of the data shown in (c) reveal that a larger exchange coupling is responsible for the slower relaxation. The contributions from ferric enzyme were subtracted from each spectrum in (a). The splitting between the lowest Kramers doublets (Δ) was obtained by fitting the linear region in (c) to [Eq. 1](#FD1){ref-type="disp-formula"}. The grey bar indicates the temperature range in which Raman relaxation modes begin to dominate the Orbach mechanism. A complete listing of Mössbauer paramaters and relaxation rates can be found in [Supplementary Tables S1 and S2](#SD1){ref-type="supplementary-material"}.](nihms-702170-f0003){#F3}

![Representative Fe K-edge EXAFS data and Fourier transforms for CPO-I (a) and CYP119A1-I (b). Raw data are shown in black and best fits are shown in red and blue, respectively. The distances shown at the right were obtained by averaging independent measurements for CPO-I and P450-I (CYP119A1-I, CYP119A2-I, and CYP158A2\*-I). These distances reveal that the Fe-S bond in P450-I is significantly shorter than in CPO-I, suggesting more electron donation from the proximal thiolate ligand to the ferryl moiety in P450. This may in part explain P450\'s greater propensity for C-H bond activation.](nihms-702170-f0004){#F4}

###### 

Best fits for compound I EXAFS data. Each row corresponds to a best fit for data obtained from measurements on an independently prepared set of samples.

                           Fe-N        Fe-S        Fe-O                                                                               
  ------------------------ ----------- ----------- -------- ----------- ----------- -------- ----------- ----------- -------- ------- -------
  CPO-I                    4           2.004       0.0011   1           2.469       0.0031   1           1.661       0.0011   −12.4   0.286
  4                        2.006       0.0010      1        2.472       0.0040      1        1.658       0.0029      −12.1    0.346   
  4                        2.001       0.0018      1        2.511       0.0129      1        1.667       0.0018      −12.3    0.331   
  4                        2.000       0.0021      1        2.472       0.0069      1        1.658       0.0047      −13.2    0.331   
                                                                                                                                      
  **Average**                          **2.003**                        **2.481**                        **1.661**                    
  **90% Conf. Interval**   **0.003**                        **0.023**                        **0.005**                                
                                                                                                                                      
  CYP119A1-I               4           2.003       0.0015   0.75        2.397       0.0045   0.75        1.667       0.0027   −12.5   0.264
  4                        1.998       0.0016      0.75     2.392       0.0045      0.75     1.672       0.0020      −13.7    0.352   
  4                        1.993       0.0013      0.65     2.374       0.0037      0.65     1.673       0.0032      −15.3    0.316   
                                                                                                                                      
  **Average**                          **1.998**                        **2.388**                        **1.670**                    
  **90% Conf. Interval**   **0.008**                        **0.020**                        **0.006**                                
  CYP119A2-I               4           1.996       0.0017   0.65        2.386       0.0067   0.65        1.669       0.0027   −14.2   0.305
  CPY158A2\*-I             4           2.010       0.0016   1           2.405       0.0102   1           1.669       0.0042   −13.4   0.364
                                                                                                                                      
  **Avg. (all P450S)**     **2.000**                        **2.391**                        **1.670**                                
  **90% Conf. Interval**   **0.006**                        **0.011**                        **0.002**                                

X-ray absorption fine structure measurements on the compound I forms of cytochrome P450 (P450) and chloroperoxidase (CPO) reveal that the Fe-S bond is significantly shorter (\~0.1 Å) in P450 than in CPO. Increased electron donation from the axial thiolate ligand may explain P450\'s greater propensity for C-H bond activation.

[^1]: Current address: Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, Menlo Park, California, 94025
